229 results
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
the meaning of the Private Securities Litigation Reform Act. These forward-looking statements include, among other things, statements regarding the structure … Financial Statements
Shareholder Litigation
Certain Adjustments
CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY
No Restraints
Shareholder Approval
6-K
EX-99.1
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
Litigation
Certain Adjustments
CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY
No Restraints
Shareholder Approval
Court Approval
Tax Rulings … set forth in the Parent Budget, make any expenditures, incur any Liabilities, settle, discharge or satisfy any claims, litigation or obligations
6-K
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
statements” within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements include, among other things, statements
6-K
EX-99.2
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
.
(d) Absence of Litigation. There is no Legal Proceeding pending or, to the knowledge of such Shareholder, threatened by, against, involving … applicable to the Parent or by which any of the Parent’s assets or properties is bound.
(c) Absence of Litigation. There is no Legal Proceeding pending
6-K
EX-99.3
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, SciSparc is using forward-looking statements
S-8
fkaoxd
1 Apr 24
Registration of securities for employees
5:11pm
6-K
EX-99.1
o9cjn3lz
27 Mar 24
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
9:18am
6-K
EX-99.1
knemd9nm
15 Mar 24
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
8:00am
6-K
2pmw0wq7
13 Mar 24
Report of Foreign Private Issuer
9:06am
6-K
EX-99.3
0z6dbngtpejas9csnn
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
6-K
EX-99.1
feljv2pivgk 889b40
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
6-K
EX-99.1
avjj4vnc ojfc9x
29 Feb 24
Report of Foreign Private Issuer
9:07am
F-1
gel7a7 k2vr
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
EX-99.1
hl2mh3bk22cy17
27 Feb 24
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
8:35am
6-K
EX-99.1
aiksw6o9 dudvo
20 Feb 24
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
4:27pm
6-K
EX-99.1
3burqilcggh ffwcn7
29 Jan 24
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
4:00pm
6-K
EX-10.1
wri3rapobghuiccnn0
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-4.1
dmrvli3wot25e6e
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-99.1
8a32ubjkxxbb t28k3oh
22 Jan 24
SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million
6:02am